Journal
FRONTIERS IN BIOSCIENCE-LANDMARK
Volume 15, Issue -, Pages 901-912Publisher
FRONTIERS IN BIOSCIENCE INC
DOI: 10.2741/3653
Keywords
Focal Adhesion Kinase; p53; cancer; Protein Interaction; Inhibitors; Tumorigenesis; Small Molecules; MDM-2; Survival; Apoptosis; Review
Categories
Funding
- Susan Komen for the Cure
- NCI
Ask authors/readers for more resources
Human cancer is characterized by a process of tumor cell motility, invasion, and metastasis. One of the critical tyrosine kinases that is linked to these processes of tumor invasion and survival is the Focal Adhesion Kinase (FAK). Our laboratory was the first to isolate FAK from human tumors, and we had demonstrated that FAK mRNA was up-regulated in invasive and metastatic human breast and colon cancer samples. We have cloned FAK promoter and have found that FAK promoter contains p53 binding sites, and that p53 inhibits FAK transcription and regulates its expression in tumor samples. In addition, we have found a high correlation between FAK overexpression and p53 mutations in 600 population-based series of breast cancer patients. found that N-myc binds FAK promoter and induces FAK transcription in neuroblastoma cells. Thus, this review will be focused on FAK and p53 signal transduction pathways in cancer.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available